Back to trial detailsIntake questionnaire
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Applying to Baylor College of Medicine Medical Center ( Site 5020) · Houston, Texas
Answer a few short questions to share with the research team.
0 of 4 answered